Unparalleled ALS Predictive Modeling Capabilities

Origent's suite of predictive models accurately predict the progression of ALS and ALS symptoms.
See our ALS Models

Managing Drug Development Risk through Better Foresight

Predicting patient-level dynamics allows researchers, drug developers, and investors better manage risks and reduce the costs of drug discovery.
Our Mission

Informed Discovery

Origent's clinical trial analysis tools help biotech firms conduct more cost efficient clinical trials and inform new experiments.
Faster Insight for Biotech

Fail Faster

We help pharmaceutical companies identify the most promising prospects in their drug development pipeline earlier, to eliminate failing projects and better prioritize scarce resources.
Earlier Knowledge for Pharma

Invest Confidently

Origent has a unique method for helping biotech investors evaluate clinical trial data during due diligence.
Venture Capital and Investors

Origent and Cytokinetics Announce Research Collaboration

Origent and Cytokinetics announce a research collaboration to refine and prospectively validate an Origent computer model to predict the course of ALS disease progression leveraging data from Cytokinetics’ clinical trials of tirasemtiv.
Read the Story

Managing Drug Development Risk through Better Foresight

Origent Logo WHITE for banner

Learn More

Pin It on Pinterest